Suppr超能文献

微小RNA-143-3p抑制卵巢癌的进展。

MiR-143-3p suppresses the progression of ovarian cancer.

作者信息

Shi Haijuan, Shen Huimin, Xu Juan, Zhao Shanshan, Yao Shuzhong, Jiang Nan

机构信息

The Second Affiliated Hospital of Guangxi Medical UniversityGuangxi, P. R. China.

The First Affiliated Hospital, Sun Yat-sen UniversityGuangzhou 510080, Guangdong, P. R. China.

出版信息

Am J Transl Res. 2018 Mar 15;10(3):866-874. eCollection 2018.

Abstract

MicroRNAs (miRNAs) are a class of naturally occurring, small, non-coding RNAs that target protein-coding mRNAs at the post-transcriptional level and participate in various biological processes. Our previous studies suggested that miR-143-3p functions as a tumor suppressor and has a role in the progression of ovarian cancer, in part through the regulation of the tumor promoter. In this study, we found that the mRNA expression level of miR-143-3p was significantly decreased in ovarian cancer tissues, in comparison with normal ovarian tissues by high-throughput miRNA profiling and quantitative RT-PCR. Secondly, we indicated that the up-regulation of miR-143-3p in the ovarian cancer cell lines SKOV3, ES2, and OVCAR3 significantly reduced their proliferation, migration, and invasion. Furthermore, miR-143-3p inhibited the growth of ovarian tumors in a xenograft experiment. In addition, miR-143-3p down-regulated the expression of transforming growth factor (TGF)-β-activated kinase 1 (TAK1) in human ovarian cancer cells. Therefore, our study indicates that miR-143-3p inhibited the proliferation, migration, and invasion of ovarian cancer cells , as well as ovarian tumorigenesis . This inhibitory effect may target TAK1, suggesting a potential application of the miR-143-3p-TAK1 pathway in the clinical diagnosis and treatment of ovarian cancer.

摘要

微小RNA(miRNA)是一类天然存在的小的非编码RNA,它们在转录后水平靶向蛋白质编码mRNA,并参与各种生物学过程。我们之前的研究表明,miR-143-3p起到肿瘤抑制因子的作用,并且在卵巢癌进展中发挥作用,部分是通过对肿瘤促进因子的调控。在本研究中,通过高通量miRNA分析和定量逆转录PCR,我们发现与正常卵巢组织相比,miR-143-3p在卵巢癌组织中的mRNA表达水平显著降低。其次,我们指出在卵巢癌细胞系SKOV3、ES2和OVCAR3中miR-143-3p的上调显著降低了它们的增殖、迁移和侵袭能力。此外,在异种移植实验中miR-143-3p抑制了卵巢肿瘤的生长。另外,miR-143-3p下调了人卵巢癌细胞中转化生长因子(TGF)-β激活激酶1(TAK1)的表达。因此,我们的研究表明miR-143-3p抑制了卵巢癌细胞的增殖、迁移和侵袭以及卵巢肿瘤发生。这种抑制作用可能靶向TAK1,提示miR-143-3p-TAK1通路在卵巢癌临床诊断和治疗中的潜在应用。

相似文献

引用本文的文献

本文引用的文献

2
miR-762 can negatively regulate menin in ovarian cancer.miR-762可在卵巢癌中负向调节Menin蛋白。
Onco Targets Ther. 2017 Apr 12;10:2127-2137. doi: 10.2147/OTT.S127872. eCollection 2017.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验